Strategic Wealth Partners’s iShares Biotechnology ETF IBB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$132K Buy
627
+14
+2% +$2.81K 0.01% 300
2026
Q2
$117K Hold
613
– – 0.01% 381
2026
Q1
$103K Hold
613
– – 0.01% 390
2025
Q4
$103K Hold
613
– – 0.01% 397
2025
Q3
$88.5K Sell
613
-604
-50% -$82.4K 0.01% 455
2025
Q2
$154K Buy
+1,217
New +$149K 0.01% 347
2023
Q3
– Sell
-33,915
Closed -$4.31M – 292
2023
Q2
$4.31M Sell
33,915
-26,284
-44% -$3.41M 0.56% 45
2023
Q1
$7.78M Buy
60,199
+9,394
+18% +$1.23M 1.19% 15
2022
Q4
$6.67M Buy
50,805
+10,945
+27% +$1.41M 1.24% 14
2022
Q3
$4.66M Buy
+39,860
New +$4.95M 0.99% 17

Other funds holding IBB

Strategic Wealth Partners's IBB Position: Q3 2026 in Review

Strategic Wealth Partners increased its iShares Biotechnology ETF (IBB) stake by 2.3% in Q3 2026, buying an estimated $2.81K and bringing the position to 627 shares worth $132K. The position accounts for 0.01% of the portfolio, ranked #300.

Strategic Wealth Partners first reported a position in IBB in Q3 2022 and has held it in 10 quarters since. The position peaked at $7.78M in Q1 2023. 1,031 funds tracked by Wall St. Rank hold IBB as of Q3 2026.

  • Strategic Wealth Partners held 627 shares of iShares Biotechnology ETF worth $132K as of Q3 2026.
  • Strategic Wealth Partners bought 14 iShares Biotechnology ETF shares in Q3 2026, an estimated $2.81K.
  • iShares Biotechnology ETF made up 0.01% of Strategic Wealth Partners's portfolio in Q3 2026, its #300 holding.
  • Strategic Wealth Partners first reported a position in iShares Biotechnology ETF in Q3 2022 and has held it in 10 quarters since.
  • Strategic Wealth Partners's iShares Biotechnology ETF position peaked at $7.78M in Q1 2023.
  • 1,031 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2026.

Based on Strategic Wealth Partners's 13F filing for Q3 2026, filed 13 Nov 2026.